scholarly article | Q13442814 |
P356 | DOI | 10.1016/0006-3223(94)00174-2 |
P698 | PubMed publication ID | 7727623 |
P50 | author | Philip B. Mitchell | Q37393406 |
Marie-Paule Austin | Q43279405 | ||
P2093 | author name string | Scott E | |
Wilhelm K | |||
Bennett B | |||
Hickie I | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
P304 | page(s) | 151-160 | |
P577 | publication date | 1995-02-01 | |
P1433 | published in | Biological Psychiatry | Q4914961 |
P1476 | title | Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression | |
P478 | volume | 37 |
Q52017096 | "Side effects" of ECT are mainly depressive phenomena and are independent of age. |
Q46042865 | 31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression |
Q73154073 | 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity |
Q37458500 | A model for intervention research in late-life depression |
Q48641104 | A preliminary profile of neuropsychological deficits associated with major depression. |
Q52024828 | A prospective follow-up study of ECT outcome in older depressed patients. |
Q37082587 | A review of etiologies of depression in COPD. |
Q48458709 | A unifying hypothesis of Alzheimer's disease. III. Risk factors. |
Q33599288 | Accelerated aging of the putamen in patients with major depressive disorder |
Q36261418 | Aging and clinical pharmacology: implications for antidepressants |
Q36955633 | Alterations of white matter integrity in adults with major depressive disorder: a magnetic resonance imaging study |
Q35188783 | Amygdala volume in late-life depression: relationship with age of onset |
Q90368732 | An Electrophysiological Biomarker That May Predict Treatment Response to ECT |
Q48516406 | Anatomic location and laterality of MRI signal hyperintensities in late-life depression. |
Q48913237 | Anatomical MRI study of basal ganglia in bipolar disorder patients. |
Q34532241 | Annual research review: progress in using brain morphometry as a clinical tool for diagnosing psychiatric disorders |
Q31135283 | Anterior cingulate dysfunction in geriatric depression |
Q26798235 | Applications of magnetic resonance imaging for treatment-resistant late-life depression |
Q33570573 | Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice |
Q34259252 | Biological basis of late life depression |
Q30799242 | Biological predictors of treatment response in affective illness |
Q31153979 | Biomarkers of cerebrovascular disease in dementia. |
Q33442474 | Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide |
Q89941156 | Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression |
Q87932898 | Brain structural connectivity in late-life major depressive disorder |
Q33884764 | Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression: a randomized, placebo-controlled study |
Q48243726 | Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression |
Q33924958 | Cerebrovascular disease and late life depression: an age old association revisited |
Q36645259 | Cerebrovascular disease basis of depression: post-stroke depression and vascular depression. |
Q39934258 | Characteristics of neurocognitive functions in mild cognitive impairment with depression |
Q37378965 | Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression |
Q34721893 | Clinical classification in mental health at the cross-roads: which direction next? |
Q48458736 | Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add-on therapy in severely depressed patients under SSRI treatment. |
Q36546373 | Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions |
Q34934354 | Comorbidity of late life depression: an opportunity for research on mechanisms and treatment |
Q34851711 | Complexity in late-life depression: impact of confounding factors on diagnosis, treatment, and outcomes |
Q48355056 | Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. |
Q36728889 | Defining melancholia: the primacy of psychomotor disturbance. |
Q74098529 | Depression in later life: three etiologically different subgroups |
Q34423873 | Depression in the elderly |
Q48084888 | Depression, vascular factors, and risk of dementia in primary care: a retrospective cohort study |
Q34991066 | Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression? |
Q34392959 | Different associations of white matter lesions with depression and cognition |
Q35155918 | Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders |
Q31034460 | Diffusion-weighted magnetic resonance imaging of white matter in bipolar disorder: a pilot study |
Q22299260 | Distinguishing Between Depression and Dementia in Older Persons: Neuropsychological and Neuropathological Correlates |
Q58295280 | Do depressive symptoms in memory-impaired elders predict probable Alzheimer's disease? |
Q57268913 | Do the Genetic or Environmental Determinants of Anxiety and Depression Change with Age? A Longitudinal Study of Australian Twins |
Q48538804 | Does neuroanatomy predict ECT response? |
Q49137375 | ECT stimulus dosing techniques. |
Q43751929 | Early and late onset depression in old age: different aetiologies, same phenomenology |
Q33964983 | Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis |
Q24248680 | Electroconvulsive therapy for the depressed elderly |
Q31391381 | Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders |
Q34013538 | Epidemiology and treatment of post-stroke depression. |
Q52543727 | Evidence of white matter tract disruption in MRI hyperintensities. |
Q45039027 | Executive dysfunction, heart disease burden, and remission of geriatric depression |
Q48068307 | Factors related to prevalence, persistence, and incidence of depressive symptoms in mild cognitive impairment: vascular depression construct |
Q21144232 | Frontal white matter anisotropy and antidepressant remission in late-life depression |
Q48306996 | Frontostriatal deficits in unipolar major depression. |
Q34641123 | Geriatric depression and cognitive impairment |
Q36951926 | Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age. |
Q90049422 | How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis |
Q33550545 | Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review |
Q30478592 | Imaging phenotypes of major depressive disorder: genetic correlates |
Q48859931 | Increased prevalence of white matter hyperintensities in patients with panic disorder. |
Q30742791 | Is late onset depression a prodrome to dementia? |
Q35111565 | Is treatment-resistant depression a unique subtype of depression? |
Q79761773 | Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients |
Q36199216 | Late-life depression: a model for medical classification. |
Q52995654 | Late-life depression: the differences between early- and late-onset illness in a community-based sample. |
Q35692848 | Late-life mood disorders |
Q46602365 | Late-onset major depression: clinical and treatment-response variability |
Q54513349 | Lobar distribution of lesion volumes in late-life depression: the Biomedical Informatics Research Network (BIRN). |
Q48414813 | Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression. |
Q34439133 | MRI findings in patients with affective disorder: a meta-analysis |
Q34160970 | MRI signal hyperintensities and treatment remission of geriatric depression |
Q44205654 | MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression |
Q43827146 | MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases |
Q37824646 | MRI-defined vascular depression: a review of the construct |
Q30724972 | Magnetic resonance imaging predictors of treatment response in late-life depression |
Q34747376 | Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke |
Q30585266 | Neuroanatomic substrates of late-life mental disorders |
Q35482688 | Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly |
Q37293670 | Neurocognitive correlates of response to treatment in late-life depression |
Q51893179 | Neurocognitive profiles in older adults with and without major depression. |
Q42379926 | Neuroimaging in geriatric psychiatry: integrative research as the next frontier |
Q31073705 | Neuroimaging in late-life depression |
Q30815738 | Neuroimaging studies of mood disorder effects on the brain |
Q34489109 | Neuropsychiatry of the basal ganglia |
Q38477042 | Outcomes focused service delivery: developing an academic-management partnership |
Q99585323 | Oxygenation differs among white matter hyperintensities, intersected fiber tracts and unaffected white matter |
Q33857662 | Pathways linking late-life depression to persistent cognitive impairment and dementia. |
Q42167218 | Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine |
Q33832945 | Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot study |
Q34739679 | Problem solving therapy for the depression-executive dysfunction syndrome of late life |
Q40368213 | Prognosis of late life depression: a three-year cohort study of outcome and potential predictors |
Q46989145 | Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER Study |
Q81569030 | Prospective study of major depressive disorder with white matter hyperintensity: comparison of patients with and without lacunar infarction |
Q47762925 | Psychiatric event in multiple sclerosis: could it be the tip of the iceberg? |
Q26822727 | Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications |
Q24629825 | Psychomotor retardation in depression: biological underpinnings, measurement, and treatment |
Q47925432 | Psychosocial and vascular risk factors of depression in later life |
Q48714695 | Quantitative evaluation of magnetic resonance imaging of deep white matter hyperintensity in geriatric patients by multifractal analysis. |
Q35014333 | Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study |
Q36885496 | Recent advances in neuroimaging biomarkers in geriatric psychiatry |
Q37374497 | Reductions in neuronal density in elderly depressed are region specific |
Q48868418 | Regional cerebral volume measurements in late-life depression: relationship to clinical correlates, neuropsychological impairment and response to treatment. |
Q35236806 | Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking |
Q37120121 | Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients |
Q48763940 | Relationship of endothelial function and atherosclerosis to treatment response in late-life depression. |
Q48379900 | Relevance of brain imaging studies for social psychiatry. |
Q34067137 | SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. |
Q44993156 | Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study |
Q34479180 | Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression |
Q45721523 | Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis |
Q73196400 | Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging |
Q33844090 | Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study |
Q33933220 | Soluble amyloid-β levels and late-life depression |
Q26765315 | Strategies to improve anxiety and depression in patients with COPD: a mental health perspective |
Q35226749 | Striatal Hypodensities, Not White Matter Hypodensities on CT, Are Associated with Late-Onset Depression in Alzheimer's Disease |
Q48438470 | Structural and functional abnormalities in elderly patients clinically recovered from early- and late-onset depression. |
Q80249687 | Structural changes in the brain in depression and relationship to symptom recurrence |
Q32127061 | Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature |
Q32062412 | Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions |
Q42420329 | Structural neuroimaging research methods in geriatric depression |
Q30769395 | Structural neuroimaging studies in late-life depression: a review |
Q48632288 | Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression--a longitudinal evaluation. |
Q48213622 | Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression |
Q36902306 | Subcortical vascular disease in elderly patients with treatment resistant depression |
Q33948757 | Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: a cross-sectional study |
Q33726069 | Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial |
Q34299420 | The Significance of Cerebral White Matter Abnormalities 100 Years After Binswanger’s Report |
Q34412882 | The anatomy of mood disorders--review of structural neuroimaging studies |
Q40523434 | The cerebrovascular model of depression in late life |
Q37792994 | The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review. |
Q48288063 | The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features |
Q35553727 | The efficacy and safety of ECT in depressed older adults: a literature review |
Q48508468 | The external validity of MRI-defined vascular depression. |
Q38389929 | The functional anatomy of psychomotor disturbances in major depressive disorder |
Q59100449 | The neurobiological pathogenesis of poststroke depression |
Q30656863 | The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review |
Q30582097 | The pathomorphology of schizophrenia and mood disorders: similarities and differences |
Q49025075 | The prognostic significance of abnormalities seen on magnetic resonance imaging in late life depression: clinical outcome, mortality and progression to dementia at three years. |
Q55163955 | The role of neuroinflammation and neurovascular dysfunction in major depressive disorder. |
Q34824971 | The vascular depression hypothesis: an update |
Q27010321 | The vascular depression hypothesis: mechanisms linking vascular disease with depression |
Q37004131 | The vascular depression subtype: evidence of internal validity |
Q34267093 | Three-dimensional surface mapping of the caudate nucleus in late-life depression |
Q35795147 | Time course of response to antidepressants in late-life major depression: therapeutic implications |
Q48530007 | Top cited papers in international psychogeriatrics: 5. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. |
Q36747232 | Translational research in late-life mood disorders: implications for future intervention and prevention research |
Q34112222 | Treatment of late-life depression: a role of non-invasive brain stimulation techniques |
Q32067550 | Treatment resistant depression in the elderly: a review of its conceptualisation, management and relationship to organic brain disease |
Q28290605 | Treatment-resistant depression: critique of current approaches |
Q41409960 | Utilising molecular biological and histopathological techniques to study the dopaminergic system in patients with melancholia |
Q31110410 | Validity of vascular depression as a specific diagnostic: a review |
Q30912417 | Value of diagnostic imaging in evaluation of electroconvulsive therapy |
Q57056107 | Vascular depression and the death of Queen Victoria |
Q42623204 | Vascular depression: overrepresented among African Americans? |
Q47843010 | Vascular risk factors in older patients with depression: outcome of electroconvulsive therapy versus medication. |
Q51951093 | Vascular risk to late-life depression: evidence from a longitudinal community study. |
Q64075368 | Volumetric Reductions of Subcortical Structures and Their Localizations in Alcohol-Dependent Patients |
Q36798672 | White matter hyperintensities: from medical comorbidities to bipolar disorders and back |
Q52931288 | [Post-stroke depression: clinical aspects, epidemiology, therapy, and pathophysiology]. |
Q79932722 | [Vascular depression: important and limited issues of the concept] |
Search more.